Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

ClinicalTrials.gov ID: NCT06384157

Public ClinicalTrials.gov record NCT06384157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Double Blind, Placebo Controlled, Randomised, Dose-Ranging Study to Assess the Safety and Efficacy of INDV-2000 Over 3 Months in Treatment Seeking Individuals With Opioid Use Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure safety and efficacy and to determine dose-response relationship for INDV-2000 in participants with moderate to severe Opioid Use Disorder (OUD) who are new to treatment, have recently initiated or completed short-term medically supervised withdrawal with transmucosal (TM) buprenorphine, and are interested in transitioning to a non opioid treatment.

Study identification

NCT ID
NCT06384157
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Indivior Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 10, 2024 (Actual)
Primary completion
Sep 29, 2025 (Actual)
Completion
Nov 3, 2025 (Actual)
Last update posted
Dec 16, 2025

2024 – 2025

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
Boyett Health Services Inc Hamilton Alabama 35570 —
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
North County Clinical Research Oceanside California 92054 —
Empire Clinical Research Pomona California 91767 —
Artemis Institute For Clinical Research - San Diego San Diego California 92103 —
Imagine Research of Palm Beach County Boynton Beach Florida 33435 —
Bold City Clinical Research Jacksonville Florida 32224 —
Vitalix Kissimmee Kissimmee Florida 34741 —
Accel Research Sites - Lakeland Lakeland Florida 33803 —
Quantum Clinical Trials Miami Beach Florida 33140 —
Segal Trials Miami Lakes Miami Lakes Florida 33016 —
Clinical Research Center of Florida Pompano Beach Florida 33060 —
Agile Clinical Research Trials Atlanta Georgia 30328 —
Maryland Treatment Centers Baltimore Maryland 21229 —
Vitalix Clinical Worcester Massachusetts 01608 —
Insight Research Institute Flint Michigan 48507 —
Precise Research Centers Flowood Mississippi 39232 —
Arch Clinical Trials St Louis Missouri 63141 —
IMA Clinical Research Las Vegas Nevada 89102 —
Oasis Clinical Research Las Vegas Nevada 89121 —
Richmond Behavioral Associates Staten Island New York 10314 —
Dr Vando Medical Services The Bronx New York 10464 —
Monroe Biomedical Research Monroe North Carolina 28112 —
West Clinical Research Morehead City North Carolina 28557 —
Midwest Clinical Research Center, LLC Dayton Ohio 45417 —
Pahl Pharmaceutical Professionals, LLC Oklahoma City Oklahoma 73112 —
SP Research PLLC Rivus Wellness and Research Insitute Oklahoma City Oklahoma 73112 —
Unity Clinical Research Oklahoma City Oklahoma 73118 —
Prisma Health Addiction Medicine Center Greenville South Carolina 29605 —
Insite Clinical Research, LLC DeSoto Texas 75115 —
El Paso Clinical Trials El Paso Texas 79902 —
HD Research Houston Texas 77043 —
Progressive Clinical Research Llc Bountiful Utah 84010 —
Alpine Research Organisation Clinton Utah 84015 —
Boeson Clinical Research Provo Utah 84604 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06384157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06384157 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →